TOP 25 HEALTHCARE PR: PROFILES
30 May 2003
With a 70 per cent hike in income to 2.7m, Galliard has nearly doubled its staff numbers.
As NHS change proceeded apace, the National Institute for Clinical Excellence (NICE) increased its influence, and pharma companies squeezed their spending, 2002 was clearly a pivotal year for healthcare PR specialists.
With a 70 per cent hike in income to 2.7m, Galliard has nearly doubled its staff numbers.
Originally published in 'Cool BrandLeaders', August 2002. The book reviews the UK's strongest cool brands as judged by the independent Brand Council Judges.
Among the many victims of the shareholder revolt at this week's GlaxoSmithKline AGM were that company's reputation for strong corporate governance, CEO Jean-Pierre Garnier's reputation for thrift and the reputation of institutional investors as the indulgent doormats of the business world.
LONDON - A group of Hollywood sound engineers serenade a family in thanks for using a Sony television to watch their film, as part of a £70m European advertising campaign for the electronics giant created by Fallon.
LONDON - Brands have lined up to donate free products to the 'Big Brother' house to capitalise on the reality show's round-the-clock, 10-week long run, and the endless column inches that accompany the programme.
LONDON - Great Universal Stores has invited four media agencies to pitch for the £42m consolidated media planning and business of its retail group Argos.
Media attacks on big pharmaceutical companies - summed up by last week's Dying for Drugs on Channel 4 - seem relentless. So is pharma the new Big Tobacco?
LONDON - Champion golfer Tiger Woods duels with a Formula 1 race car in his debut commercial for the luxury watch brand TAG Heuer, in a spot called 'Who can beat Tiger Woods?'.
As consumerism develops, so the consumer demands on companies grow. In an era when customers expect more and more from companies (and certainly more than just basic product delivery), they are also becoming more cynical about the corporate sector as a whole, and multinationals in particular.